• How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • New path to profits in biotech: Taking the acquisition exit

    November 16, 2006 | Healthcare | Journal of Commercial Biotechnology

    The paper aims to demonstrate that biotech start-ups increasingly are choosing trade sales to large pharma or biotech players to move their drug discoveries into the marketplace.

  • Innovation suppressants

    September 14, 2006 | Healthcare | The Economic Times

    Confronted by the government's plan to impose price controls on hundreds of medicines, Indian pharmaceutical producers recently chose instead to cap the profit margins they make on many commonly used drugs.

  • A cancer for drug makers

    June 20, 2006 | Healthcare | The Wall Street Journal Europe

    The battle over Herceptin, the drug for breast cancer that this month won preliminary approval for broader use from U.K. health regulators, was a bruising affair that focused public attention on the high price of a shot at survival.

  • India's wake-up call in pharma

    June 18, 2006 | Healthcare | The Economic Times

    India's age-old rivalry with China has suddenly turned sharp in a cutting-edge industry - pharmaceuticals. Last month (May 26), global drug maker AstraZeneca unveiled plans to invest $100 million over the next three years in an 'innovation centre' in China.

  • Reference pricing for drugs

    April 13, 2006 | Healthcare |

    That certain drugs are interchangeable in terms of their health benefits is the idea behind "reference pricing," in which officials judge the therapeutic effectiveness of drugs within a disease group and reimburse based on the least expensive option.

  • Where will Indian drug companies be in five years? Everywhere - if they innovate

    March 22, 2006 | Healthcare | Bain Brief

    India's pharmaceutical industry has arrived at a cross roads. Well positioned compared with China as an arena for drug development and reliable, low cost manufacturing, India's pharma capabilities are strong and growing fast.